Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pepys, 1975, Skin testing, Br J Hosp Med (Lond), 14, 412
Piette, 2002, Prick tests to aeroallergens: is it possible simply to wipe the device between tests?, Allergy, 57, 940, 10.1034/j.1398-9995.2002.23536.x
Masse, 2011, Comparison of five techniques of skin prick tests used routinely in Europe, Allergy, 66, 1415, 10.1111/j.1398-9995.2011.02679.x
Brown, 1979, The relationship of respiratory allergy, skin test reactivity, and serum IgE in a community population sample, J Allergy Clin Immunol, 63, 328, 10.1016/0091-6749(79)90127-1
Nelson, 1993, Comparative performance of five commercial prick skin test devices, J Allergy Clin Immunol, 92, 750, 10.1016/0091-6749(93)90019-C
Bock, 1977, Proper use of skin tests with food extracts in diagnosis of hypersensitivity to food in children, Clin Allergy, 7, 375, 10.1111/j.1365-2222.1977.tb01466.x
Skassa-Brociek, 1987, Skin test reactivity to histamine from infancy to old age, J Allergy Clin Immunol, 80, 711, 10.1016/0091-6749(87)90292-2
Australasian Society of Clinical Immunology and Allergy. Skin Prick Testing for the diagnosis of allergic diseases – A Manual for Practitioners [http://www.allergy.org.au/health-professionals/papers/skin-prick-testing], 2006, Revised May 2013.
Liccardi, 2006, Systemic reactions from skin testing: literature review, J Investig Allergol Clin Immunol, 16, 75
Lockey, 1987, Fatalities from immunotherapy (IT) and skin testing (ST), J Allergy Clin Immunol, 79, 660, 10.1016/S0091-6749(87)80164-1
Bernstein, 2004, Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001, J Allergy Clin Immunol, 113, 1129, 10.1016/j.jaci.2004.02.006
Norrman, 2009, Adverse reactions to skin prick testing in children - prevalence and possible risk factors, Pediatr Allergy Immunol, 20, 273, 10.1111/j.1399-3038.2008.00761.x
Turkeltaub, 1989, The risk of adverse reactions from percutaneous prick-puncture allergen skin testing, venipuncture, and body measurements: data from the second National Health and Nutrition Examination Survey 1976-80 (NHANES II), J Allergy Clin Immunol, 84, 886, 10.1016/0091-6749(89)90384-9
Valyasevi, 1999, Systemic reactions to allergy skin tests, Ann Allergy Asthma Immunol, 83, 132, 10.1016/S1081-1206(10)62624-5
Swender, 2012, The rate of epinephrine administration associated with allergy skin testing in a suburban allergy practice from 1997 to 2010, Allergy Rhinol (Providence), 3, e55, 10.2500/ar.2012.3.0034
Devenney, 2000, Skin prick tests may give generalized allergic reactions in infants, Ann Allergy Asthma Immunol, 85, 457, 10.1016/S1081-1206(10)62571-9
Bernstein, 2008, Allergy diagnostic testing: an updated practice parameter, Ann Allergy Asthma Immunol, 100, S1
Bousquet, 2012, Practical guide to skin prick tests in allergy to aeroallergens, Allergy, 67, 18, 10.1111/j.1398-9995.2011.02728.x
Lockey, 1989, The Hymenoptera venom study II. Skin test results and safety of venom skin testing, J Allergy Clin Immunol, 84, 967, 10.1016/0091-6749(89)90396-5
Strohmeier, 2013, Simultaneous intradermal testing with Hymenoptera venoms is safe and more efficient than sequential testing, Allergy, 68, 542, 10.1111/all.12123
Yocum, 1996, Safety and efficacy of an accelerated method for venom skin testing, J Allergy Clin Immunol, 97, 1424, 10.1016/S0091-6749(96)70217-8
Golden, 2011, Stinging insect hypersensitivity: A practice parameter update 2011, J Allergy Clin Immunol, 127, 852, 10.1016/j.jaci.2011.01.025
Cox, 2008, Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy Asthma and Immunology/American Academy of Allergy Asthma and Immunology Specific IgE Test Task Force, Ann Allergy Asthma Immunol, 101, 580, 10.1016/S1081-1206(10)60220-7
Kränke, 2009, Skin testing for IgE-mediated drug allergy, Immunol Allergy Clin N Am, 29, 503, 10.1016/j.iac.2009.04.003
Barbaud, 2009, Skin testing in delayed reactions to drugs, Immunol Allergy Clin N Am, 29, 517, 10.1016/j.iac.2009.04.010
Romano, 2002, Diagnosing nonimmediate reactions to penicillins by in vivo tests, Int Arch Allergy Immunol, 129, 169, 10.1159/000065876
Brockow, 2013, Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper, Allergy, 68, 702, 10.1111/all.12142
Barbaud, 1998, The use of skin testing in the investigation of cutaneous adverse drug reactions, Br J Dermatol, 139, 49, 10.1046/j.1365-2133.1998.02313.x
Romano, 2008, Patch testing in non-immediate drug eruptions, Allergy, Asthma and Clin Immunol, 4, 66, 10.1186/1710-1492-4-2-66
Rive, 2013, Testing for drug hypersensitivity syndromes, Clin Biochem Rev, 34, 15
Brockow, 2002, General considerations for skin test procedures in the diagnosis of drug hypersensitivity, Allergy, 57, 45
Barbaud, 2001, Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions, Contact Dermatitis, 45, 321, 10.1034/j.1600-0536.2001.450601.x
Alanko, 1993, Patch testing in cutaneous reactions caused by carbamazepine, Contact Dermatitis, 29, 254, 10.1111/j.1600-0536.1993.tb03560.x
Barbaud, 2004, Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins, Contact Dermatitis., 50, 22, 10.1111/j.0105-1873.2004.00280.x
Mashiah, 2003, A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis, Arch Dermatol, 139, 1181, 10.1001/archderm.139.9.1181
van Kampen, 2000, Occupational airway sensitizers: an overview on the respective literature, Am J Ind Med., 38, 164, 10.1002/1097-0274(200008)38:2<164::AID-AJIM7>3.0.CO;2-2
Baur, 2014, Allergens causing occupational asthma: an evidence-based evaluation of the literature, Int Arch Occup Environ Health., 87, 339, 10.1007/s00420-013-0866-9
van Kampen, 2013, Evaluation of commercial skin prick test solutions for selected occupational allergens, Allergy, 68, 651, 10.1111/all.12116
Bergman, 1995, Contact urticaria with anaphylactic reactions caused by occupational exposure to iridium salt, Contact Dermatitis., 32, 14, 10.1111/j.1600-0536.1995.tb00833.x
Van Kampen, 2013, EAACI position paper: skin prick testing in the diagnosis of occupational type I allergies, Allergy., 68, 580, 10.1111/all.12120
Cabañes, 2012, SEAIC. Latex allergy: Position Paper, J Investig Allergol Clin Immunol., 22, 313
Chua, 2013, Prevalence of latex allergy in spina bifida patients in Singapore, Asia Pac Allergy., 3, 96, 10.5415/apallergy.2013.3.2.96
Kelly, 1993, Skin and serologic testing in the diagnosis of latex allergy, J Allergy Clin Immunol., 91, 1140, 10.1016/0091-6749(93)90316-8
Hamilton, 1998, Diagnosis of natural rubber latex allergy: multicenter latex skin testing efficacy study. Multicenter Latex Skin Testing Study Task Force, J Allergy Clin Immunol, 102, 482, 10.1016/S0091-6749(98)70139-3
Hamilton, 2002, Clinical and laboratory-based methods in the diagnosis of natural rubber latex allergy, J Allergy Clin Immunol, 110, S47, 10.1067/mai.2002.125334
Accetta Pedersen, 2012, Analysis of available diagnostic tests for latex sensitization in an at-risk population, Ann Allergy Asthma Immunol., 108, 94, 10.1016/j.anai.2011.11.009
Nettis, 2001, Systemic reactions on SPT to latex, Allergy., 56, 355, 10.1034/j.1398-9995.2001.00862.x
Ravensberg, 2007, Validated safety predictions of airway responses to house dust mite in asthma, Clin Exp Allergy, 37, 100, 10.1111/j.1365-2222.2006.02617.x
Taylor, 2000, Comparison of incremental and bolus dose inhaled allergen challenge in asthmatic subjects, Clin Exp Allergy, 30, 56, 10.1046/j.1365-2222.2000.00657.x
Moscato, 2012, EAACI consensus statement for investigation of work-related asthma in non-specialized centres, Allergy, 67, 491, 10.1111/j.1398-9995.2011.02784.x
Schulze, 2013, Bronchial allergen challenges in children - safety and predictors, Pediatr Allergy Immunol, 24, 19, 10.1111/pai.12031
Melillo G, Bonini S, Cocco O, Davies RJ, de Monchy GR, Frolund L, Pelikan Z. EAACI provocation tests with allergens. Report prepared by the European Academy of Allergology and Clinical Immunology Subcommittee on provocation tests with allergens. Allergy. 1997;52 (suppl.35):5-36.
Barnig, 2013, Nonallergic airway hyperresponsivenss and allergen-specific IgE levels are the main determinants of the early and late asthmatic response to allergen, J Investig Allergol Clin Immunol, 23, 267
Vandenplas, 2013, Incidence of severe asthmatic reactions after challenge exposure to occupational agents, Chest, 143, 1261, 10.1378/chest.12-1983
Bousquet, 2007, Safety conditions for allergic challenge tests realization, Rev Fr Allergol Immunol Clin, 47, 323
Kowalski, 2011, Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA, Allergy, 66, 818, 10.1111/j.1398-9995.2011.02557.x
Dahlén, 1998, Inhalation challenge in ASA-induced asthma, Respir Med, 92, 378, 10.1016/S0954-6111(98)90279-7
Melillo, 2001, Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma, Allergy, 56, 899, 10.1034/j.1398-9995.2001.00025.x
Nizankowska-Mogilnicka, 2007, EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity, Allergy, 62, 1111, 10.1111/j.1398-9995.2007.01409.x
Kowalski, 2013, Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs, Allergy, 68, 1219, 10.1111/all.12260
Hussein, 1989, The incidence of analgesics intolerance in asthmatic children detected by history and inhalation challenge with lysine acetylsalicylate, Klin Padiatr, 201, 1, 10.1055/s-2007-1025266
Melillo, 1993, Dosimeter inhalation test with lysine acetylsalicylate for the detection of aspirin-induced asthma, Ann Allergy, 71, 61
Park, 1995, Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients, Clin Exp Allergy, 25, 38, 10.1111/j.1365-2222.1995.tb01000.x
Nizankowska, 2000, Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma, Eur Respir J, 15, 863, 10.1034/j.1399-3003.2000.15e09.x
Makowska, 2008, Systemic responses after bronchial aspirin challenge in sensitive patients with asthma, J Allergy Clin Immunol, 121, 348, 10.1016/j.jaci.2007.09.039
Phillips, 1989, Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: its repeatability, absence of a late-phase reaction, and the role of histamine, J Allergy Clin Immunol, 84, 232, 10.1016/0091-6749(89)90330-8
Cockcroft, 2010, Direct challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance, Chest, 138, 18S, 10.1378/chest.10-0088
Anderson, 2010, Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance, Chest, 138, 25S, 10.1378/chest.10-0116
Parkerson, 2011, Mannitol as an indirect bronchoprovocation test for the 21st century, Ann Allergy Asthma Immunol, 106, 91, 10.1016/j.anai.2010.11.010
Cockcroft, 2006, Mechanisms of airway hyperresponsiveness, J Allergy Clin Immunol, 118, 551, 10.1016/j.jaci.2006.07.012
Sont, 1999, Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group, Am J Respir Crit Care Med, 159, 1043, 10.1164/ajrccm.159.4.9806052
Sastre, 2003, Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge, Chest, 123, 1276, 10.1378/chest.123.4.1276
Schulze, 2012, Methacholine challenge in young children as evaluated by spirometry and impulse oscillometry, Respir Med, 106, 627, 10.1016/j.rmed.2012.01.007
Crapo, 2000, Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999, Am J Respir Crit Care Med, 161, 309, 10.1164/ajrccm.161.1.ats11-99
1997, Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies, Eur Respir J, 10, 2662, 10.1183/09031936.97.10112662
Pratter, 1993, Bronchodilator reversal of bronchospasm and symptoms incurred during methacholine bronchoprovocation challenge. Documentation of safety and time course, Chest, 104, 1342, 10.1378/chest.104.5.1342
Subbarao, 2005, Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy, J Allergy Clin Immunol, 115, 745, 10.1016/j.jaci.2004.11.023
Devillier, 2011, The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy, Allergy, 66, 163, 10.1111/j.1398-9995.2010.02473.x
Gosepath, 2005, Nasal provocation testing as an international standard for evaluation of allergic and nonallergic rhinitis, Laryngoscope, 115, 512, 10.1097/01.MLG.0000149682.56426.6B
Tantilipikorn, 2010, Nasal provocation test: how to maximize its clinical use?, Asian Pac J Allergy Immunol, 28, 225
Zerah-Lancer, 2009, Usefulness of nasal provocation tests in occupational rhinitis, Rhinology, 47, 432
Rondón, 2014, Follow-up study in local allergic rhinitis shows a consistent entity not evolving to systemic allergic rhinitis, J Allergy Clin Immunol, 133, 1026, 10.1016/j.jaci.2013.10.034
Pawankar, 2011, Burden of Disease: Rhinitis, Conjunctivitis, Rhinosinusitis, 27
Dordal, 2011, Allergen-specific nasal provocation testing: review by the rhinoconjunctivitis committee of the Spanish Society of Allergy and Clinical Immunology, J Investig Allergol Clin Immunol, 21, 1
Kanthawatana, 1997, Evaluation of threshold criteria for the nasal histamine challenge test in perennial allergic rhinitis, Asian Pac J Allergy Immunol, 15, 65
Rondon, 2010, Local allergic rhinitis: concept, clinical manifestations, and diagnostic approach, J Investig Allergol Clin Immunol, 20, 364
Tuskan, 2010, The value and safety of specific nasal provocation in the diagnosis of allergic rhinitis in mild persistent asthma under inhaled steroid therapy, Asian Pac J Allergy Immunol, 28, 115
Wojdas, 2005, Nasal provocative test in patients allergic to pollen, Ann Agric Environ Med, 12, 173
Passalacqua, 2013, Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language, J Allergy Clin Immunol, 132, 93, 10.1016/j.jaci.2013.03.039
Lee, 2010, Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 105, 130, 10.1016/j.anai.2010.05.020
Miller, 2013, Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease: asthma and rhinitis, Clin Exp Allergy, 43, 874, 10.1111/cea.12110
Makowska, 2015, Hypersensitivity to aspirin and other NSAIDs: Diagnostic approach in patients with chronic rhinosinusitis, Curr Allergy Asthma Rep, 15, 47, 10.1007/s11882-015-0552-y
Tichenor, 2008, Nasal and sinus endoscopy for medical management of resistant rhinosinusitis, including postsurgical patients, J Allergy Clin Immunol, 121, 917, 10.1016/j.jaci.2007.08.065
Van Spronsen, 2008, Evidence-based recommendations regarding the differential diagnosis and assessment of nasal congestion: using the new GRADE system, Allergy, 63, 820, 10.1111/j.1398-9995.2008.01729.x
Amine, 2013, Outcomes of endoscopy and computed tomography in patients with chronic rhinosinusitis, Int Forum Allergy Rhinol, 3, 73, 10.1002/alr.21071
Fokkens, 2012, European Position Paper on Rhinosinusitis and Nasal Polyps 2012, Rhinology, 50, 1
Alobid, 2014, Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis, Laryngoscope, 124, 50, 10.1002/lary.24330
Berger, 2011, The contribution of flexible endoscopy for diagnosis of acute bacterial rhinosinusitis, Eur Arch Otorhinolaryngol, 268, 235, 10.1007/s00405-010-1329-5
Marseglia, 2007, The 10-day mark is a good way to diagnose not only acute rhinosinusitis but also adenoiditis, as confirmed by endoscopy, Int J Pediatr Otorhinolaryngol, 71, 581, 10.1016/j.ijporl.2006.12.003
Meltzer, 2004, Rhinosinusitis: establishing definitions for clinical research and patient care, J Allergy Clin Immunol, 114, 155, 10.1016/j.jaci.2004.09.029
Hellings, 2012, Executive summary of European Task Force document on diagnostic tools in rhinology, Rhinology, 50, 339, 10.4193/Rhino11.252
Nowak-Wegrzyn, 2009, Work Group report: oral food challenge testing, J Allergy Clin Immunol, 123, S365, 10.1016/j.jaci.2009.03.042
Bock, 1988, Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual, J Allergy Clin Immunol, 82, 986, 10.1016/0091-6749(88)90135-2
Sampson, 2012, Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report, J Allergy Clin Immunol, 130, 1260, 10.1016/j.jaci.2012.10.017
Ahrens, 2014, Positive reactions to placebo in children undergoing double-blind, placebo-controlled food challenge, Clin Exp Allergy, 44, 572, 10.1111/cea.12284
Sicherer, 1999, Food allergy: when and how to perform oral food challenges, Pediatr Allergy Immunol, 10, 226, 10.1034/j.1399-3038.1999.00040.x
Bindslev-Jensen, 2004, Standardization of food challenges in patients with immediate reactions to foods-position paper from the European Academy of Allergology and Clinical Immunology, Allergy, 59, 690, 10.1111/j.1398-9995.2004.00466.x
Liebermann, 2011, Outcomes of office-based. Open food challenges in the management of food allergy, J Allergy Clin Immunol, 128, 1120, 10.1016/j.jaci.2011.07.012
Untersmayr, 2008, The role of protein digestibility and antacids on food allergy outcomes, J Allergy Clin Immunol, 121, 1301, 10.1016/j.jaci.2008.04.025
Boyce, 2010, Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel, J Allergy Clin Immunol, 126, S1
Rancé, 2009, Oral food challenge in children: an expert review, Eur Ann Allergy Clin Immunol, 41, 35
Fleischer, 2011, Oral food challenges in children with a diagnosis of food allergy, J Pediatr, 158, 578, 10.1016/j.jpeds.2010.09.027
Bock, 2007, Further fatalities caused by anaphylactic reactions to food, 2001-2006, J Allergy Clin Immunol, 119, 1016, 10.1016/j.jaci.2006.12.622
Cianferoni, 2013, Oral food challenge to wheat: a near-fatal anaphylaxis and review of 93 food challenges in children, World Allergy Organ J, 6, 14, 10.1186/1939-4551-6-14
Perry, 2004, Risk of oral food challenges, J Allergy Clin Immunol, 114, 1164, 10.1016/j.jaci.2004.07.063
Sicherer, 2000, Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis, J Allergy Clin Immunol, 105, 582, 10.1067/mai.2000.104941
Järvinen, 2009, Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children, J Allergy Clin Immunol, 124, 1267, 10.1016/j.jaci.2009.10.006
Rolinck-Werninghaus, 2012, Outcome of oral food challenges in children in relation to symptom-eliciting allergen dose and allergen-specific IgE, Allergy, 67, 951, 10.1111/j.1398-9995.2012.02838.x
Peters, 2012, The predictive value of skin prick testing for challenge-proven food allergy: a systematic review, Pediatr Allergy Immunol, 23, 347, 10.1111/j.1399-3038.2011.01237.x
Ahrens, 2012, Organ-specific symptoms during oral food challenge in children with food allergy, J Allergy Clin Immunol, 130, 549, 10.1016/j.jaci.2012.05.045
Calvani, 2012, Oral food challenge: safety, adherence to guidelines and predictive value of skin prick testing, Pediatr Allergy Immunol, 23, 755, 10.1111/pai.12016
Niggemann, 2012, Accurate oral food challenge requires a cumulative dose on a subsequent day, J Allergy Clin Immunol, 130, 261, 10.1016/j.jaci.2012.03.021
Sampson, 2011, A phase II, randomized, double blind, parallel group, placebo controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy, J Allergy Clin Immunol, 127, 1309, 10.1016/j.jaci.2011.01.051
Leonard, 2011, Food protein-induced enterocolitis syndrome: an update on natural history and review of management, Ann Allergy Asthma Immunol, 107, 95, 10.1016/j.anai.2011.06.004
Aberer, 2003, European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations, Allergy, 58, 854, 10.1034/j.1398-9995.2003.00279.x
Messaad, 2004, Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction, Ann Intern Med, 140, 1001, 10.7326/0003-4819-140-12-200406150-00009
Aberer, 2009, Provocation tests in drug hypersensitivity, Immunol Allergy Clin North Am, 29, 567, 10.1016/j.iac.2009.04.008
Torres, 2003, Diagnosis of immediate allergic reactions to beta-lactam antibiotics, Allergy, 58, 961, 10.1034/j.1398-9995.2003.00280.x
Romano, 2004, ENDA; EAACI: Diagnosis of non-immediate reactions to betalactamantibiotics, Allergy, 59, 1153, 10.1111/j.1398-9995.2004.00678.x
Blanca, 2009, Update on the evaluation of hypersensitivity reactions to beta-lactams, Allergy, 64, 183, 10.1111/j.1398-9995.2008.01924.x
Torres, 2012, Diagnostic evaluation of patients with non-immediate cutaneous hypersensitivity reactions to iodinated contrast media, Allergy, 67, 929, 10.1111/j.1398-9995.2012.02840.x
Macy, 2007, Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper, Ann Allergy Asthma Immunol, 98, 172, 10.1016/S1081-1206(10)60692-8
Mirakian, 2009, BSACI: BSACI guidelines for the management of drug allergy, Clin Exp Allergy, 39, 43, 10.1111/j.1365-2222.2008.03155.x
2010, Drug allergy: an updated practice parameter, Ann Allergy Asthma Immunol, 105, 259, 10.1016/j.anai.2010.08.002
du Toit, 2011, The RCPCH care pathway for children with drug allergies: an evidence and consensus basednational approach, Arch Dis Child, 96, i15, 10.1136/archdischild-2011-300116
Po, 2001, Causality assessment of adverse effects: when is re-challenge ethically acceptable?, Drug Saf, 24, 793, 10.2165/00002018-200124110-00001
Romano, 1999, A diagnostic protocol for evaluationg nonimmediate reactions to aminopenicillins, J Allergy Clin Immunol, 103, 1186, 10.1016/S0091-6749(99)70197-1
Toogood, 1988, Risk of anaphylaxis in patients receiving b-blocker drugs, J Allergy Clin Immunol, 81, 1, 10.1016/0091-6749(88)90212-6
Drain, 2001, Preventing and managing drug-induced anaphylaxis, Drug Saf, 24, 843, 10.2165/00002018-200124110-00005
Ruëff, 1996, The sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology, Allergy, 51, 216
Hunt, 1978, A controlled trial of immunotherapy in insect hypersensitivity, N Engl J Med, 299, 157, 10.1056/NEJM197807272990401
Franken, 1994, Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity, J Allergy Clin Immunol, 93, 431, 10.1016/0091-6749(94)90351-4
Koschel, 2014, Tolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of life, J Investig Allergol Clin Immunol., 24, 226
Müller, 1992, Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety, J Allergy Clin Immunol, 89, 529, 10.1016/0091-6749(92)90319-W
Haeberli, 2003, Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy, Clin Exp Allergy, 33, 1216, 10.1046/j.1365-2222.2003.01755.x
Ruëff, 2013, Clinical effectiveness of Hymenoptera venom immunotherapy. A prospective observational multicenter study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity, PlosONE, 8, e63233, 10.1371/journal.pone.0063233
Ruëff, 2014, Predictors of clinical effectiveness of Hymenoptera venom immunotherapy, Clin Exp Allergy, 44, 736, 10.1111/cea.12275
Bonaparte, 2011, A double-blind randomised controlled trial assessing the efficacy of topical lidocaine in extended flexible endoscopic nasal examinations, Clin Otolaryngol, 36, 550, 10.1111/j.1749-4486.2011.02403.x
Urisu, 2011, Japanese guideline for food allergy, Allergol Int, 60, 221, 10.2332/allergolint.11-RAI-0329
Golden, 1981, Dose dependence of Hymenoptera venom immunotherapy, J Allergy Clin Immunol, 67, 370, 10.1016/0091-6749(81)90082-8
Bousquet, 1988, Systemic reactions during maintenance immunotherapy with honey bee venom, Ann Allergy, 61, 63
Ruëff, 2001, Patients still reacting to a sting challenge while receiving Hymenoptera venom immunotherapy are protected by increased venom doses, J Allergy and Clin Immunol, 108, 1027, 10.1067/mai.2001.119154
Niedoszytko, 2009, Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy, Allergy, 64, 1237, 10.1111/j.1398-9995.2009.02118.x
Golden, 1996, Discontinuing venom immunotherapy: outcome after five years, J Allergy Clin Immunol, 97, 579, 10.1016/S0091-6749(96)70302-0
Herxeimer, 1951, Bronchial hypersensitization and hyposensitization in man, Int Arch Allergy Appl Immunol, 2, 40, 10.1159/000227899
Taylor, 1972, Local nasal desensitization in allergic rhinitis, Clin Allergy, 2, 125, 10.1111/j.1365-2222.1972.tb01277.x
Taudorf, 1983, Orally administered grass pollen, Allergy, 38, 561, 10.1111/j.1398-9995.1983.tb04140.x
Canonica, 2003, Non injection routes for immunotherapy, J Allergy Clin Immunol, 111, 437, 10.1067/mai.2003.129
Alvarez-Cuesta, 2006, Standards for practical allergen-specific immunotherapy, Allergy, 61, 1, 10.1111/j.1398-9995.2006.01219_1.x
Cox, 2011, Allergen immunotherapy: a practice parameter third update, J Allergy Clin Immunol, 127, S1, 10.1016/j.jaci.2010.09.034
Simioni, 2013, Efficacy of venom immunotherapy given every 3 or 4 months: a prospective comparison with the conventional regimen, Ann Allergy Asthma Immunol, 110, 51, 10.1016/j.anai.2012.09.014
Canonica, 2009, Sublingual immunotherapy: WAO Position Paper 2009. Canonica GW et al edts, Allergy, 64, 3
1993, (EAACI) The European Academy of Allergology and Clinical Immunology, Allergy, 48, 36
World Health Organization Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Bousquet J, Lockey R, Malling HJ edts. Allergy 1998;102:558–62.
Muller, 1990, Insect sting allergy – Clinical picture, diagnosis and treatment, Gustav Fischer Ed, 3, 33
Cox, 2010, Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System, J Allergy Clin Immunol, 125, 569, 10.1016/j.jaci.2009.10.060
Simons, 2012, 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis, Curr Opin Allergy Clin Immunol, 12, 389, 10.1097/ACI.0b013e328355b7e4
Rands, 1980, Anaphylactic reaction to desensitization for allergic rhinitis and asthma, BMJ, 281, 854, 10.1136/bmj.281.6244.854
Rands, 1983, Side effects of desensitization for allergy: a general practice survey, J R Coll Gen Pract, 33, 647
Cox, 2009, Comparison of allergen immunotherapy practice patterns in the United States and Europe, Ann Allergy Asthma Immunol, 103, 451, 10.1016/S1081-1206(10)60259-1
Reid, 1992, Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol. 1993;92(1 Pt 1):6-15Stewart GE, Lockey RF Systemic reactions from allergen immunotherapy, J Allergy Clin Immunol, 90, 567
Epstein, 2009, Fatal and Systemic Reactions to Subcutaneous Immunotherapy: ACAAI/AAAAI National Surveillence Study After One Year, Ann Allergy Asthma Immunol, 103, A23
Rank, 2008, Allergen immunotherapy safety: Characterizing systemic reactions and identifying risk factors, Allergy Asthma Proc, 29, 400, 10.2500/aap.2008.29.3141
Lockey, 2001, Systemic reactions and fatalities associated with allergen immunotherapy, Ann Allergy Asthma Immunol, 87, 47, 10.1016/S1081-1206(10)62195-3
Amin, 2006, Evaluation of near-fatal reactions to allergen-immunotherapy injections, J Allergy Clin Immunol, 117, 169, 10.1016/j.jaci.2005.10.010
Epstein, 2013, AAAi and ACAAI surveillance study of subcutaneous immuntherapy: year 3. What pracice modify the risk of systemic reactions?, Ann Allergy Asthma Immunol, 110, 274, 10.1016/j.anai.2013.01.015
Windom, 2008, An update on the safety of specific immunotherapy, Curr Opin Allergy Clin Immunol, 8, 571, 10.1097/ACI.0b013e32831845fb
Malling, 1998, Immunotherapy as an effective tool in allergy treatment, Allergy, 53, 461, 10.1111/j.1398-9995.1998.tb04082.x
Schiappoli, 2009, A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy, Clin Exp Allergy, 39, 1569, 10.1111/j.1365-2222.2009.03286.x
Schiappoli M, Ridolo E, Senna G, et al. A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. Clin Exp Allergy. 2009;39:1569–74.
Aaronson, 2004, Incorrect allergy injections: allergists’ experiences and recommendations for prevention, J Allergy Clin Immunol, 113, 1117, 10.1016/j.jaci.2004.01.756
Roy, 2007, Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy, Ann Allergy Asthma Immunol, 99, 82, 10.1016/S1081-1206(10)60626-6
Linneberg, 2012, Allergen-specific immunotherapy and risk of autoimmune disease, Curr Opin Allergy Clin Immunol, 12, 635, 10.1097/ACI.0b013e3283588c8d
Shaikh, 1993, A retrospective study on the safety of immunotherapy in pregnancy, Clin Exp Allergy, 23, 857, 10.1111/j.1365-2222.1993.tb00264.x
Shaikh, 2012, A prospective study on the safety of sublingual immunotherapy in pregnancy, Allergy, 67, 741, 10.1111/j.1398-9995.2012.02815.x
Marshall, 1999, AIDS, HIV-positive patients, and allergies, Allergy Asthma Proc, 20, 301, 10.2500/108854199778251979
Hepner, 1990, Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections, J Allergy Clin Immunol, 86, 407, 10.1016/S0091-6749(05)80105-8
Ohashi, 2006, Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis, Ann Allergy Asthma Immunol, 96, 600, 10.1016/S1081-1206(10)63556-9
Canonica, 2014, Sublingual immunotherapy: World Allergy Organization position paper 2013 update, World Allergy Organ J, 7, 6, 10.1186/1939-4551-7-6
Bonifazi, 2005, Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice, Allergy, 60, 1459, 10.1111/j.1398-9995.2005.00960.x
Brown, 2003, Ant venom immunotherapy: a double-blind placebo-controlled, crossover trial, Lancet, 361, 1001, 10.1016/S0140-6736(03)12827-9
Oude-Elberink, 2009, Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings, Clin Exp Allergy, 39, 883, 10.1111/j.1365-2222.2009.03230.x
Sasvary, 1994, Fatalities from insect sting from 1978 to 1987, Schweiz Med Wochenschr, 124, 1887
Müller, 2007, Cardiovascular disease and anaphylaxis, Curr Opin Allergy Clin Immunol, 7, 337, 10.1097/ACI.0b013e328259c328
Brown, 2012, Ultrarush versus semirush initiation of insect venom immunotherapy: a randomized controlled trial, J Allergy Clin Immunol, 130, 162, 10.1016/j.jaci.2012.02.022
Müller, 2005, Use of betablockers during immunotherapy for Hymenoptera venom allergy, J Allergy Clin Immunol, 115, 606, 10.1016/j.jaci.2004.11.012
Ruëff, 2010, Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase, J Allergy Clin Immunol, 126, 105, 10.1016/j.jaci.2010.04.025
Bonadonna, 2010, Mastocytosis and insect venom allergy, Curr Opin Clin Allergy Immunol, 10, 347, 10.1097/ACI.0b013e32833b280c
Bilo, 2010, Purified vs non purified venom immunotherapy, Curr Opin Allergy Clin Immunol, 10, 330, 10.1097/ACI.0b013e328339f2d1
Rueff, 2004, Specific immunotherapy in honey bee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations, Allergy, 59, 589, 10.1111/j.1398-9995.2004.00505.x
Simons, 2013, World Allergy Organization Anaphylaxis Guidelines: 2013 Update of the Evidence Base, Int Arch Allergy Immunol, 162, 193, 10.1159/000354543
Müller, 2008, Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venomimmunotherapy, J Allergy Clin Immunol, 122, 1001, 10.1016/j.jaci.2008.08.007
Galera, 2009, Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab, J Investig Allergol Clin Immunol, 19, 225
Yeung, 2012, Oral immunotherapy for milk allergy, Cochrane Database of Syst Rev, 11, CD009542
Nurmatov, 2014, Effectiveness and safety of orally administered immunotherapy for food allergies: a systematic review and meta-analysis, Br J Nutr, 111, 12, 10.1017/S0007114513002353
Beyer, 2012, A European perspective on immunotherapy for food allergies, J Allergy Clin Immunol, 129, 1179, 10.1016/j.jaci.2012.03.037
Anagnostou, 2014, Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial, Lancet, 383, 1297, 10.1016/S0140-6736(13)62301-6
Wood, 2014, Oral immunotherapy for the treatment of peanut allergy: is it ready for prime time?, JACI: In Practice, 2, 97
Muraro, 2014, EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy, Allergy, 69, 1008, 10.1111/all.12429
Lucendo, 2014, Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis, Ann Allergy Asthma Immunol, 113, 624, 10.1016/j.anai.2014.08.004
Cernadas, 2010, General considerations on rapid desensitization for drug hypersensitivity - a consensus statement, Allergy, 65, 1357, 10.1111/j.1398-9995.2010.02441.x
Scherer, 2013, Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group, Allergy, 68, 844, 10.1111/all.12161
Legere, 2009, A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity, J Cyst Fibros, 8, 418, 10.1016/j.jcf.2009.08.002
Gastaminza, 2011, A new rapid desensitization protocol for chemotherapy agents, J Investig Allergol Clin Immunol, 21, 108
Castells, 2008, Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases, J Allergy Clin Immunol, 122, 574, 10.1016/j.jaci.2008.02.044
Stevenson, 1984, Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin, J Allergy Clin Immunol, 73, 500, 10.1016/0091-6749(84)90361-0
Kitazawa, 2006, Successful vancomycin desensitization with a combination of rapid and slow infusion methods, Intern Med, 45, 317, 10.2169/internalmedicine.45.1388
Kobashi, 2010, Desensitization therapy for allergic reactions to antituberculous drugs, Intern Med, 49, 2297, 10.2169/internalmedicine.49.3590
Rossini, 2008, Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation, Am J Cardiol, 101, 786, 10.1016/j.amjcard.2007.10.045
Slowik, 2009, Aspirin desensitization in a patient with aspirin sensitivity and chronic idiopathic urticaria, Ann Allergy Asthma Immunol, 102, 171, 10.1016/S1081-1206(10)60252-9
Cernadas, 2013, Desensitization to antibiotics in children, Pediatr Allergy Immunol, 24, 3, 10.1111/pai.12001
de Groot, 2010, Clinical Practice: drug desensitization in children, Eur J Pediatr, 169, 1305, 10.1007/s00431-010-1236-1
Hope, 2009, Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease, J Allergy Clin Immunol, 123, 406, 10.1016/j.jaci.2008.09.048
Wong, 2000, Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema, J Allergy Clin Immunol, 105, 997, 10.1067/mai.2000.104571
Feldweg, 2005, Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments, Gynecol Oncol, 96, 824, 10.1016/j.ygyno.2004.11.043
Brennan, 2009, Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment, J Allergy Clin Immunol, 124, 1259, 10.1016/j.jaci.2009.09.009
Whitaker, 2011, Rapid desensitization for non-immediate reactions in patients with cystic fibrosis, J Cyst Fibros, 10, 282, 10.1016/j.jcf.2011.02.002
Breslow, 2009, Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization, Ann Allergy Asthma Immunol, 102, 155, 10.1016/S1081-1206(10)60247-5
Madrigal-Burgaleta, 2013, Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment, Allergy, 68, 853, 10.1111/all.12105
Eisenhauer, 1994, European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion, J Clin Oncol, 12, 2654, 10.1200/JCO.1994.12.12.2654
White, 2006, Effect of leukotriene modifier drugs on the safety of oral aspirin challenges, Ann Allergy Asthma Immunol, 97, 688, 10.1016/S1081-1206(10)61101-5
Long, 2014, Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab, J Allergy Clin Immunol, 134, 560, 10.1016/j.jaci.2014.02.007
Jensen-Jarolim, 2008, AllergoOncology: the role of IgE-mediated allergy in cancer, Allergy, 63, 1255, 10.1111/j.1398-9995.2008.01768.x
Cooper, 2008, Geohelminth infections: a review of the role of IgE and assessment of potential risks of anti-IgE treatment, Allergy, 63, 409, 10.1111/j.1398-9995.2007.01601.x
Leiva-Salinas, 2014, Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C. J Eur Acad Dermatol Venereol. 2015;29:1027-8Baena-Cagnani CE, Gómez RM. Current status of therapy with omalizumab in children, Curr Opin Allergy Clin Immunol, 14, 149
Baena-Cagnani, 2014, Current status of therapy with omaizumab in children, Curr Opin Allergy Clin Immunol, 14, 149, 10.1097/ACI.0000000000000044
Somerville, 2014, Immunogenicity and safety of omalizumab in pre-filled syringes in patients with allergic (IgE-mediated) asthma, Curr Med Res Opin, 30, 59, 10.1185/03007995.2013.844115
Chipps, 2012, Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma, Allergy Asthma Proc, 33, 377, 10.2500/aap.2012.33.3599
Thomson, 2012, Omalizumab: clinical use for the management of asthma, Clin Med Insights Circ Respir Pulm Med, 6, 27, 10.4137/CCRPM.S7793
Corren, 2009, Safety and tolerability of omalizumab, Clin Exp Allergy, 39, 788, 10.1111/j.1365-2222.2009.03214.x
Maurer, 2013, Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria, N Engl J Med, 7, 924, 10.1056/NEJMoa1215372
Kim, 2010, Omalizumab: Practical considerations regarding the risk of anaphylaxis, Allergy Asthma Clin Immunol, 6, 32, 10.1186/1710-1492-6-32
XOLAIR [prescribing information and medication guide]. South San Francisco, CA: Genentech, Inc; 2014. Accessed at: http://www.xolair.com/.
Cox, 2007, American Academy of Allergy, Asthma, & Immunology; American College of Allergy, Asthma, and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis, J Allergy Clin Immunol, 120, 1373, 10.1016/j.jaci.2007.09.032
Stiehm, 2013, Adverse effects of human immunoglobulin therapy, Transfus Med Rev, 27, 171, 10.1016/j.tmrv.2013.05.004
Chapel, 2013, Subcutaneous immunoglobulin replacement therapy: the European experience, Curr Opin Allergy Clin Immunol, 13, 623, 10.1097/ACI.0000000000000013
Niebur, 2015, Efficacy and tolerability of 16 % subcutaneous immunoglobulin compared with 20 % subcutaneous immunoglobulin in primary antibody deficiency, Clin Exp Immunol, 181, 441, 10.1111/cei.12623
Bork, 2013, Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review, Allergy Asthma Proc, 34, 312, 10.2500/aap.2013.34.3677
Bork, 2014, Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema, Immunotherapy, 6, 533, 10.2217/imt.14.33
Spath, 2015, On the dark side of therapies with immunoglobulin concentrates: the adverse events, Front Immunol, 6, 11, 10.3389/fimmu.2015.00011
Simons, 2011, World Allergy Organization Guidelines for the assessment and management of anaphylaxis, WAO Journal, 4, 13
Simons, 2014, International consensus on (ICON) anaphylaxis, World Allergy Org J, 7, 9, 10.1186/1939-4551-7-9
Muraro, 2014, Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology, Allergy, 69, 1026, 10.1111/all.12437
Spaner, 1989, Hypersensitivity to natural latex, J Allergy Clin Immunol, 83, 1135, 10.1016/0091-6749(89)90457-0
Bonnekoh, 1992, Safety of latex prick skin testing in allergic patients, JAMA, 267, 2603, 10.1001/jama.1992.03480190045019